Active Biotech Financials
| ACTI Stock | SEK 0.12 0.01 9.09% |
Active |
Understanding current and past Active Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Active Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Active Biotech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Active Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Active Biotech AB. Check Active Biotech's Beneish M Score to see the likelihood of Active Biotech's management manipulating its earnings.
Active Biotech Stock Summary
Active Biotech competes with BioInvent International, Orexo AB, Alligator Bioscience, Swedish Orphan, and Anoto Group. Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunityinflammatory, and cancer. Active Biotech AB was incorporated in 1982 and is based in Lund, Sweden. Active Biotech operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0001137985 |
| Business Address | Scheelevgen 22, Lund, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.activebiotech.com |
| Phone | 46 46 19 20 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Active Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Active Stock, because this is throwing your money away. Analyzing the key information contained in Active Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Active Biotech Key Financial Ratios
Active Biotech's financial ratios allow both analysts and investors to convert raw data from Active Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Active Biotech over time and compare it to other companies across industries.| Return On Equity | -1.44 | |||
| Return On Asset | -0.67 | |||
| Target Price | 3.0 | |||
| Beta | 0.53 |
Active Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Active Biotech's current stock value. Our valuation model uses many indicators to compare Active Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Active Biotech competition to find correlations between indicators driving Active Biotech's intrinsic value. More Info.Active Biotech AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Active Biotech's earnings, one of the primary drivers of an investment's value.Active Biotech AB Systematic Risk
Active Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Active Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Active Biotech AB correlated with the market. If Beta is less than 0 Active Biotech generally moves in the opposite direction as compared to the market. If Active Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Active Biotech AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Active Biotech is generally in the same direction as the market. If Beta > 1 Active Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Active Biotech Thematic Clasifications
Active Biotech AB is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Active Biotech December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Active Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Active Biotech AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Active Biotech AB based on widely used predictive technical indicators. In general, we focus on analyzing Active Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Active Biotech's daily price indicators and compare them against related drivers.
| Downside Deviation | 15.88 | |||
| Information Ratio | 0.0149 | |||
| Maximum Drawdown | 221.37 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 11.76 |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.